Special Issue "New Technologies and Theories for Tumor Drug Development"
Deadline for manuscript submissions: closed (31 May 2023) | Viewed by 3028
Interests: tumor metastasis; miRNA detection; fluorescence; photothermal therapy; nanomaterials; tumor resistance
Interests: targeted delivery systems; nanoparticle delivery systems; traditional Chinese medicines (TCMs)
Interests: medicinal chemistry; organic synthesis; drug development; natural products; hybridization; antitumoral; immunotherapy
Special Issues, Collections and Topics in MDPI journals
In recent years, the development of anti-tumor drugs has ushered in rapid development, with the emergence of new drugs often being accompanied by new theoretical breakthroughs. Attention has been paid to the development trends of anti-tumor drugs. Such drugs include nano targeted materials, small-molecule drugs, immune drugs, and characteristic Chinese herbal medicine. In this Special Issue, entitled “New Technologies and Theories for Tumor Drug Development”, we invite the submission of original research articles or reviews on different aspects of this emerging research field.
Areas of interest include, but are not limited to:
- Nano targeted materials;
- Small-molecule drugs and immune drugs;
- Characteristic Chinese herbal medicine;
- Mechanisms of tumor metastasis drug intervention.
Dr. Jie Wang
Dr. Jihui Tang
Dr. Angela Patricia Hernandez
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- chemotherapy drugs
- nano targeted materials
- mechanisms of tumor metastasis
- Chinese herbal medicine